Xpert® Xpress Flu/RSV
Rapid detection and differentiation of Flu A, Flu B, or RSV in as soon as 20 minutes.^
Sign in or create a MyCepheid account to add items to cart
Test pack size(s)
product image
10 Tests
XPRSFLU/RSV-CE-10
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Collection devices
product image
Nasopharyngeal Collection Kit (Pack of 100)
SWAB/B-100
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
product image
Nasal Collection Kit (Pack of 100)
SWAB/F-100
Qty
Unit price
Subtotal
USD
Product is not available for purchase in your region.
Total
{{currency}}
0
Error adding items to cart. If this error persists, please contact Digital Support

The Need

  • In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections1
  • Sensitivities of Rapid EIA Flu tests range from 50-70%2
  • Sensitivities of Rapid Antigen RSV tests average 29% in adults3
  • Both Rapid EIA and Antigen manufacturers suggest confirming negative results with RT-PCR or culture2
  • Rapid RSV tests may have age limitations4
(1) Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13.
(2) CDC. Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Accessed Sep 2016. http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm
(3)Chartrand C, et al. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015 Dec;53(12):3738-49.
(4) BD Veritor™ System –For Rapid Detection of Flu A+B. Package Insert. DB. Dublin, Ireland. 2014.

The Solution

  • Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes*
  • Enables healthcare providers to quickly deliver targeted therapies
  • Steamlines laboratory operations
  • Improves patient satisfaction
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.

The Impact

  • Single-test confidence will accelerate your laboratory's workflow with on-demand, random-access flexibility. Combine performance with the capability to run other Xpert® tests (including GBS, MRSA, C. difficile, CT/NG, and MTB/RIF) on Cepheid's GeneXpert® System to achieve proven productivity increases in overall laboratory service.5-9
  • Be Proactive
  • Achieve rapid results and improve patient management
  • Early assay termination option: deliver positive results in as soon as 20 minutes* and negative results in 30 minutes
  • Quickly deliver targeted therapies and increase peace of mind for patients
* For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes.
^ For positive results with Flu only or RSV only reporting
(5) Morgan MG. The Perfect Storm. Cepheid Impact. 2012 Jun;2:4-7.
(6) Parada JP. Increase Revenue and Improve Patient Safety. Cepheid Impact. 2012 Jun;2:8-11.
(7) El Helali N. Less Uncertainty - Better Safety - More Healthy Newborns. Cepheid Impact. 2012 Jul;3:4-7.
(8) Haynes L. The C. difficile Challenge. Cepheid Impact. 2012 Jul;3:10-15.
(9) Parada JP. Improving Patient Safety. Cepheid Impact. 2012 Oct;4:8-11.